FIELD: chemistry.
SUBSTANCE: invention relates to a novel 5-methyl-6-nitro-7-oxo-4,7-dihydro-1,2,4-triazolo[1,5-α]pyrimidinide l-argininium monohydrate of formula (1)  The compound has antiviral activity with respect to group A and B strain viruses in in vitro and in vivo systems.
 The compound has antiviral activity with respect to group A and B strain viruses in in vitro and in vivo systems.
EFFECT: compound has low toxicity.
4 dwg, 3 tbl, 4 ex
| Title | Year | Author | Number | 
|---|---|---|---|
| INJECTION OR INFUSION SOLUTION OF L-ARGININE SALT OF 5-METHYL-6-NITRO-1,2,4-TRIAZOLO[1,5-a] PYRIMIDIN-7-ONE MONOHYDRATE FOR THERAPY OF INFLUENZA AND OTHER VIRAL INFECTIONS | 2014 | 
 | RU2586283C1 | 
| AZOLOAZINE SALTS OF FLUOROQUINOLONES, POSSESSING ANTIBACTERIAL AND ANTIVIRAL ACTION | 2014 | 
 | RU2547835C1 | 
| METHOD FOR QUANTITATIVE DETERMINATION OF TRIAZIDE BY VOLTAMMETRY | 2019 | 
 | RU2733397C2 | 
| SODIUM SALT OF 2-METHYLTHIO-6-CYANO-1,2,4-TRIAZOLO[5,1-C]-1,2,4-TRIAZIN-7(4H)-ONE, TRIHYDRATE | 2015 | 
 | RU2607628C1 | 
| SODIUM SALT 5-METHYL-6-NITRO-1,2,4-TRIAZOLE[1,5-a]PYRIMIDINE-7-ONE DIHYDRATE | 2006 | 
 | RU2330036C1 | 
| INJECTION SOLUTION FOR TREATING VIRAL DISEASES SPECIFIED IN H1N1, H3N2, H5N1 INFLUENZA, TICK-BORNE ENCEPHALITIS AND WEST NILE FEVER | 2013 | 
 | RU2574007C2 | 
| SODIUM SALT OF 2-METHYL-6-FLUORO-1,2,4-TRIAZOLO[5,1-c]-1,2,4-TRIAZIN-7(4H)-ONE DIHYDRATE, HAVING ANTIVIRAL ACTIVITY | 2009 | 
 | RU2493158C2 | 
| MEDICATION POSSESSING ANTI-VIRAL ACTIVITY AND CONTAINING 2-METHYLTHIO-5-METHYL-6-NITRO-1,2,4-TRIAZOLO[1,5-a]PYRIMIDIN-7(3H)-ON | 2007 | 
 | RU2365591C2 | 
| ETHYL ESTER OF 2-(ADAMANTAN-1-yl)-3-BROMO-7-OXO-4,7-DIHYDROPYRAZOLO[1,5-a]PYRIMIDINE-6-CARBOXYLIC ACID, HAVING ANTIVIRAL ACTION ON SARS-CoV-2 CORONAVIRUS | 2024 | 
 | RU2839407C1 | 
| CONJUGATES OF 2-METHYLTHIO-6-NITRO-1,2,4-TRIAZOLO[5,1-c]-1,2,4-TRIAZIN-7(4I')-ONE WITH GLUTADIONE AND OTHER PEPTIDES, POSSESSING ANTIVIRAL ACTIVITY | 2012 | 
 | RU2516936C2 | 
Authors
Dates
2014-09-27—Published
2013-04-15—Filed